510(k) Report

510(k) · Cleared

Cleared

Caption Guidance

K201992510(k) TraditionalCleared Sep 18, 202063-day reviewClass II21 CFR 892.2100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Caption Health · QJU Image Acquisition And/Or Optimization Guided By Artificial Intelligence

Cleared on Sep 18, 2020 as substantially equivalent to K200755 (Caption Health, 2020) after a 63-day review. Its family tree reaches back 2 generations to 2020. 1 later device descends from it.

Decided
Sep 18, 2020
Review
63 days
Class
Class II
Product code
QJU
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN190040 (2020). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2025: 1 descendant clearedDEN190040 · Caption Guidance · Bay Labs, Inc. · 2020K200755 · Caption Guidance · Caption Health · 20202020202220242026
Descendants, by generation 1 generation forward: 1 descendant K200755 · Caption Guidance · Caption Health · 2020DEN190040 · Caption Guidance · Bay Labs, Inc. · 20200
  1. Root · 2 generations backDEN190040 Caption GuidanceBay Labs, Inc. · 2020
  2. 1 generation backK200755 Caption GuidanceCaption Health · 2020
  3. This deviceK201992 Caption GuidanceCaption Health · 2020
  4. Descendant · cites it directly · 0 of its ownK243065 Cardiac GuidanceCaption Health, Inc. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K243065Cardiac GuidanceCaption Health, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN190040Caption GuidanceBay Labs, Inc.2020—
−1K200755Caption GuidanceCaption Health2020—
0 (this device)K201992Caption GuidanceCaption Health2020—
+1K243065Cardiac GuidanceCaption Health, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K201992, 2020–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJU device

  1. #1 K242807 HeartFocus (V.1.1.1)score 12.1 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K200755Caption Guidance
Summary page 4
…lassification Name: Image Acquisition And/Or Optimization Guided By Artificial Intelligence Regulatory Class: II Product Code: QJU Predicate Device: Caption Guidance (K200755) Device Description: The Caption Guidance software is a radiological computer assisted acquisition guidance system that provide…
Caption Health2020—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K243065Cardiac GuidanceCaption Health, Inc.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 0 years and passes through 2 companies; a new generation was cleared every 5 months on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K243065 (Caption Health, Inc., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QJU devices

QJU Image Acquisition And/Or Optimization Guided By Artificial Intelligence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · QJU

3in 2025

2020: 32023: 12025: 32026 (partial year): 3
2007high 3 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJU

199in 2025

2025: 199 days median2026 (partial year): 163 days median
2007high 199 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QJU

No recall names QJU since 2007.

Adverse event reports per year · QJU

No MAUDE report names QJU since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20203—00
20210—00
20220—00
20231—00
20240—00
2025319900
202631630—

What is it indicated for?

The Caption Guidance software is intended to assist medical professionals in the acquisition of cardiac ultrasound images. The Caption Guidance software is an accessory to compatible general purpose diagnostic ultrasound systems. The Caption Guidance software is indicated for use in two-dimensional transthoracic echocardiography (2D-TTE) for adult patients, specifically in the acquisition of the following standard views: Parasternal Long-Axis (PLAX)…

Read the full statement (101 words)

The Caption Guidance software is intended to assist medical professionals in the acquisition of cardiac ultrasound images. The Caption Guidance software is an accessory to compatible general purpose diagnostic ultrasound systems.

The Caption Guidance software is indicated for use in two-dimensional transthoracic echocardiography (2D-TTE) for adult patients, specifically in the acquisition of the following standard views: Parasternal Long-Axis (PLAX), Parasternal Short-Axis at the Aortic Valve (PSAX-AV), Parasternal Short-Axis at the Mitral Valve (PSAX-MV), Parasternal Short-Axis at the Papillary Muscle (PSAX-PM), Apical 4-Chamber (AP4), Apical 5-Chamber (AP5), Apical 2-Chamber (AP2), Apical 3-Chamber (AP3), Subcostal 4-Chamber (SubC4), and Subcostal Inferior Vena Cava (SC-IVC).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K201992: Caption Guidance.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K201992

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026